This webinar will highlight opportunities for research collaboration.

This webinar is intended to educate on emerging knowledge on transporter activity modulation in disease state like liver Cirrhosis/hepatic impairment, and its implications on PK in specific populations.

This webinar will highlight the challenges and limitations for prediction of in vivo clearance for aldehyde oxidase (AO) substrates in human.

This webinar aims to introduce various tools/platforms, the use of primary human hepatocyte spheroids, cryo-electron microscopy, and bioengineered microRNA, in drug transporter research and drug discovery.

Attendees will be educated on utility of mathematical models to characterize ADME of TPs. Emerging modeling approaches will be introduced and recent case examples will be discussed.

This webinar aims to highlight current knowledge about albumin-mediated uptake by organic anion transporters expressed in liver and kidney. Special emphasis will be placed on in vitro evidence to support the hypothesis and the complexity confounded by the non-specific binding of the drug-albumin complex. Speakers: Mengyue (Melody) Yin, University of Washington, USA Shawn Pei Feng Tan, University of Manchester, UK Panelists: Aleksandra Galetin, University of Manchester, UK Jash Unadkat , University of Washington, USA Yuichi Sugiyama, Josai International University, Japan

This webinar will advance that once free drug is correctly interpreted it can move “projected clinical dose” to a holistic central role in the objectives of drug discovery programs, rather than a checklist of arbitrary multiple objectives.

This webinar is going to extend the discussion initiated in the award lecture that was presented in Seattle in September 2022 in recognition of my sustained contributions to the field of drug metabolism research.